CVE-2025-61940

HIGH EPSS 20.5%
Published Dec 2, 20257mo ago · Modified Jun 17, 20262w ago
8.7 CVSS 4.0
High
Find Similar
Published Dec 2, 2025 7mo ago
Last Modified Jun 17, 2026 2w ago

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

CVSS Details

Base Score
8.7
Exploitability
—
Impact
—
Vector string
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Attack Vector Network
Attack Complexity Low
Privileges Required Low
User Interaction None
Scope X

Threat Intelligence

EPSS Exploit Probability
20.5% percentile
Exploit & Patch Status
No Known Exploit
No Patch Available

Weaknesses 1

CWE-603

Affected Products 1

VendorProductVersionRange
mirionbiodose\/nmis* <23.0

References 1

  • cisa.gov https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01
    Third Party Advisory

Remediation

No remediation data recorded yet

Check vendor advisories and the NVD entry for patch availability.